TNFα and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics
- 1 April 2006
- Vol. 38 (4) , 509-520
- https://doi.org/10.1016/j.bone.2005.10.007
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Endogenous Protein Kinase Inhibitor γ Terminates Immediate-early Gene Expression Induced by cAMP-dependent Protein Kinase (PKA) SignalingPublished by Elsevier ,2005
- Parathyroid Hormone Stimulates Receptor Activator of NFκB Ligand and Inhibits Osteoprotegerin Expression via Protein Kinase A Activation of cAMP-response Element-binding ProteinJournal of Biological Chemistry, 2002
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Importance of Membrane- or Matrix-Associated Forms of M-CSF and RANKL/ODF in Osteoclastogenesis Supported by SaOS-4/3 Cells Expressing Recombinant PTH/PTHrP ReceptorsJournal of Bone and Mineral Research, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- The Cell-surface Form of Colony-stimulating Factor-1 Is Regulated by Osteotropic Agents and Supports Formation of Multinucleated Osteoclast-like CellsPublished by Elsevier ,1998
- Parathyroid hormone (1-34)–mediated interleukin-6 inductionJournal of Cellular Biochemistry, 1997
- Serum Interleukin-6 and Bone Metabolism in Patients with Thyroid Function DisordersJournal of Clinical Endocrinology & Metabolism, 1997
- Cell Type and Stimulus Specific Regulation of Chemokine Gene ExpressionBiochemical and Biophysical Research Communications, 1994
- Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesisBiochemical and Biophysical Research Communications, 1989